Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 10 studies | 21% ± 6% | |
peripheral blood | 10 studies | 23% ± 10% | |
brain | 6 studies | 30% ± 11% | |
pancreas | 3 studies | 35% ± 15% | |
eye | 3 studies | 22% ± 5% | |
lymph node | 3 studies | 19% ± 2% | |
intestine | 3 studies | 21% ± 5% | |
liver | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9783.92 | 1445 / 1445 | 100% | 33.29 | 183 / 183 |
lung | 100% | 11429.69 | 578 / 578 | 100% | 40.45 | 1155 / 1155 |
ovary | 100% | 9781.41 | 180 / 180 | 100% | 34.02 | 430 / 430 |
pancreas | 100% | 5881.04 | 328 / 328 | 100% | 38.29 | 178 / 178 |
prostate | 100% | 13143.57 | 245 / 245 | 100% | 56.41 | 502 / 502 |
skin | 100% | 7812.09 | 1809 / 1809 | 100% | 46.84 | 472 / 472 |
stomach | 100% | 8149.32 | 359 / 359 | 100% | 34.66 | 286 / 286 |
thymus | 100% | 11712.21 | 653 / 653 | 100% | 52.67 | 605 / 605 |
uterus | 100% | 10988.13 | 170 / 170 | 100% | 39.56 | 459 / 459 |
brain | 100% | 6793.82 | 2634 / 2642 | 100% | 51.91 | 705 / 705 |
intestine | 100% | 11084.49 | 966 / 966 | 100% | 36.90 | 525 / 527 |
bladder | 100% | 9569.52 | 21 / 21 | 100% | 39.64 | 502 / 504 |
kidney | 100% | 9270.06 | 89 / 89 | 99% | 37.67 | 895 / 901 |
breast | 100% | 9872.23 | 459 / 459 | 99% | 46.32 | 1110 / 1118 |
adrenal gland | 100% | 11374.83 | 258 / 258 | 99% | 42.07 | 228 / 230 |
liver | 100% | 4520.47 | 226 / 226 | 99% | 25.29 | 401 / 406 |
adipose | 100% | 9313.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 46.14 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 35.27 | 29 / 29 |
muscle | 100% | 8426.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 13527.21 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.48 | 1 / 1 |
blood vessel | 100% | 7870.01 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 5127.01 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 10672.38 | 920 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905515 | Biological process | non-motile cilium assembly |
GO_0061512 | Biological process | protein localization to cilium |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0006897 | Biological process | endocytosis |
GO_1904948 | Biological process | midbrain dopaminergic neuron differentiation |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0007165 | Biological process | signal transduction |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0071539 | Biological process | protein localization to centrosome |
GO_0007020 | Biological process | microtubule nucleation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0034067 | Biological process | protein localization to Golgi apparatus |
GO_0007030 | Biological process | Golgi organization |
GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
GO_0051225 | Biological process | spindle assembly |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_2000052 | Biological process | positive regulation of non-canonical Wnt signaling pathway |
GO_0048208 | Biological process | COPII vesicle coating |
GO_0005876 | Cellular component | spindle microtubule |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CSNK1D |
Protein name | Casein kinase 1 delta Casein kinase I isoform delta (EC 2.7.11.26) (Tau-protein kinase CSNK1D) Casein kinase I isoform delta (EC 2.7.11.1) (EC 2.7.11.26) (Tau-protein kinase CSNK1D) Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) |
Synonyms | HCKID |
Description | FUNCTION: Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. In balance with PP1, determines the circadian period length through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. Phosphorylates NEDD9/HEF1 (By similarity). EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. . |
Accessions | B4DLF1 J3QQI9 ENST00000584672.1 ENST00000580446.1 ENST00000269361.11 J3KRM8 ENST00000392334.7 [P48730-2] ENST00000314028.11 [P48730-1] H7BYT1 ENST00000580784.5 ENST00000398519.9 J3QQU8 P48730 ENST00000403276.7 ENST00000585026.1 J3KRS6 ENST00000581660.5 J3QS70 H0Y2N6 |